Table 6.
Biochemical indicators after 8-wk treatment (mean ± SD)
Group | Time | n | PTA (%) | n | TBIL (µmol/L) | n | ALB (g/L) | n | ALT (IU/L) |
MMC | Before treatment | 28 | 26.80 ± 10.91 | 30 | 326.29 ± 210.47 | 28 | 28.07 ± 4.56 | 30 | 202.00 ± 249.20 |
After treatment | 18 | 43.14 ± 18.60 | 21 | 176.13 ± 185.70 | 21 | 28.57 ± 4.56 | 21 | 39.90 ± 30.19 | |
“TQD” | Before treatment | 61 | 32.50 ± 12.15 | 65 | 314.04 ± 160.20 | 65 | 29.54 ± 4.75 | 65 | 254.80 ± 424.32 |
After treatment | 55 | 43.59 ± 22.08 | 63 | 242.54 ± 229.05 | 63 | 31.30 ± 4.77c | 63 | 78.70 ± 161.80 | |
“TTK” | Before treatment | 36 | 28.63 ± 11.28 | 36 | 369.13 ± 198.06 | 36 | 27.82 ± 4.52 | 36 | 189.52 ± 241.97 |
After treatment | 30 | 32.55 ± 15.58 | 33 | 339.40 ± 270.09a | 33 | 30.72 ± 2.89e | 33 | 70.12 ± 82.23 |
Normal range: PTA: 80%-120%; TBIL: 3.4-20.5 μmol/L; ALB: 35-55 g/L; ALT: 0-46 IU/L.
P < 0.05 vs MMC group;
P < 0.05 vs MMC group,
P < 0.05 vs MMC group.